Table 2.
Year-wise distribution of various pathologic types of lung cancer
| Years | SCC | ADC | NSCLC (NOS) | SCLC | Others |
|---|---|---|---|---|---|
| 2008 (n=63) | 16 (25.4) | 6 (9.5) | 31 (49.2) | 10 (15.9) | 0 (0) |
| 2009 (n=48) | 11 (22.9) | 5 (10.4) | 25 (52.1) | 7 (14.6) | 0 (0) |
| 2010 (n=67) | 13 (19.4) | 10 (14.9) | 29 (43.3) | 15 (22.4) | 0 (0) |
| 2011 (n=70) | 21 (30) | 15 (21.4) | 24 (34.3) | 10 (14.3) | 0 (0) |
| 2012 (n=103) | 26 (25.2) | 37 (35.9) | 25 (24.3) | 14 (13.6) | 1 (1.0) |
| 2013 (n=154) | 41 (26.6) | 57 (37.0) | 21 (13.6) | 33 (21.4) | 2 (1.4) |
| 2014 (n=233) | 75 (32.2) | 79 (34.0) | 33 (14.1) | 40 (17.2) | 6 (2.5) |
| 2015 (n=286) | 83 (29.0) | 89 (31.1) | 42 (14.7) | 59 (20.6) | 13 (4.6) |
| 2016 (n=359) | 101 (28.1) | 162 (45.1) | 32 (9.0) | 51 (14.2) | 13 (3.6) |
| 2017 (n=376) | 115 (30.6) | 137 (36.4) | 54 (14.4) | 54 (14.4) | 16 (4.2) |
| Upto March 2018 (n=103) | 30 (29.1) | 37 (35.9) | 22 (21.4) | 7 (6.8) | 7 (6.8) |
ADC: Adenocarcinoma, SCC: Squamous cell carcinoma, SCLC: Small-cell lung cancer, NSCLC: Non-SCLC, NOS: Not otherwise specified